SNP/haplotype associations of CCR2 and CCR5 genes with severity of chagasic cardiomyopathy

Human Immunology

Volumn 75, Issue 12, 2014, Pages 1210-1215

  Machuca, Mayra Alejandra ^a   Suárez, Edwin Uriel ^b   Echeverría, Luis Eduardo ^b   Martín, Javier ^c   González, Clara Isabel ^a  

^a UNIVERSIDAD INDUSTRIAL DE SANTANDER   (Colombia)

^b FUNDACIÓN CARDIOVASCULAR DE COLOMBIA   (Colombia)

^c INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

Author keywords

CCR2; CCR5; Chagasic cardiomyopathy; Colombia; Single nucleotide polymorphism (SNP)

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CCR2 PROTEIN, HUMAN; CCR5 PROTEIN, HUMAN;

ALLELE; ARTICLE; CHAGAS DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE CLUSTER; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REPLICATION STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; COHORT ANALYSIS; FEMALE; GENETICS; IMMUNOLOGY; INFLAMMATION; MALE; MIDDLE AGED; TRYPANOSOMA CRUZI;

CHAGAS CARDIOMYOPATHY; CHAGAS DISEASE; COHORT STUDIES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; HAPLOTYPES; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CCR2; RECEPTORS, CCR5; TRYPANOSOMA CRUZI;

EID: 84927557714     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2014.09.023     Document Type: Article

References (34)

1. Lee B.Y., Bacon K.M., Bottazzi M.E., Hotez P.J. Global economic burden of Chagas disease: a computational simulation model. Lancet Infect Dis 2013, 13:342-348.
2. WHO World Health Organization The Global Burden of Disease: 2004 Update 2008, World Health Organization, Geneva.
3. OPS Organización Panamericana de la Salud Estimación cuantitativa de la Enfermedad de Chagas en las Américas 2006, Buenos Aires, Argentina, p. 17-20.
4. WHO World Health Organization Working to overcome the global impact of neglected tropical diseases: first WHO report on neglected tropical diseases 2010, World Health Organization, Geneva.
5. Lee B.Y., Bacon K.M., Connor D.L., Willig A.M., Bailey R.R. The potential economic value of a Trypanosoma cruzi (Chagas disease) vaccine in Latin America. PLoS Negl Trop Dis 2010, 4:e916.
6. Nunes M.C., Dones W., Morillo C.A., Encina J.J., Ribeiro A.L. Chagas disease: an overview of clinical and epidemiological aspects. J Am College Cardiol 2013, 62:767-776.
7. Pereira Nunes M.d.C., Barbosa M.M., Ribeiro A.L.P., Amorim Fenelon L.M., Rocha M.O.C. Predictors of mortality in patients with dilated cardiomyopathy relevance of chagas disease as an etiological factor. Revista Española de Cardiología (English Version) 2010, 63:788-797.
8. Talvani A., Teixeira M.M. Inflammation and Chagas disease some mechanisms and relevance. Adv Parasitol 2011, 76:171-194.
9. Zhao Q. Dual targeting of CCR2 and CCR5: therapeutic potential for immunologic and cardiovascular diseases. J Leukoc Biol 2010, 88:41-55.
10. Rocha Rodrigues D.B., dos Reis M.A., Romano A., Pereira S.A., Teixeira Vde P., et al. In situ expression of regulatory cytokines by heart inflammatory cells in Chagas' disease patients with heart failure. Clin Dev Immunol 2012, 361730.
11. Nogueira L.G., Santos R.H., Ianni B.M., Fiorelli A.I., Mairena E.C., et al. Myocardial chemokine expression and intensity of myocarditis in Chagas cardiomyopathy are controlled by polymorphisms in CXCL9 and CXCL10. PLoS Negl Trop Dis 2012, 6:e1867.
12. Florez O., Martin J., Gonzalez C.I. Genetic variants in the chemokines and chemokine receptors in Chagas disease. Hum Immunol 2012, 73:852-858.
13. Calzada J.E., Nieto A., Beraun Y., Martin J. Chemokine receptor CCR5 polymorphisms and Chagas' disease cardiomyopathy. Tissue Antigens 2001, 58:154-158.
14. Fernandez-Mestre M.T., Montagnani S., Layrisse Z. Is the CCR5-59029-G/G genotype a protective factor for cardiomyopathy in Chagas disease?. Hum Immunol 2004, 65:725-728.
15. Mordini O.D., Mitelman J. Clasificación Enfermedad de Chagas 2010, Consenso Internacional, Buenos Aires, Available from: http://www.fac.org.ar/1/comites/chagas/Clasificacion_Enfermedad_de_Chagas.pdf.
16. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16:1215.
17. Gonzalez E., Bamshad M., Sato N., Mummidi S., Dhanda R., et al. Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes. Proc Natl Acad Sci USA 1999, 96:12004-12009.
18. Mamtani M., Mummidi S., Ramsuran V., Pham M.H., Maldonado R., et al. Influence of variations in CCL3L1 and CCR5 on tuberculosis in a northwestern Colombian population. J Infect Dis 2011, 203:1590-1594.
19. Mummidi S., Bamshad M., Ahuja S.S., Gonzalez E., Feuillet P.M., et al. Evolution of human and non-human primate CC chemokine receptor 5 gene and mRNA. Potential roles for haplotype and mRNA diversity, differential haplotype-specific transcriptional activity, and altered transcription factor binding to polymorphic nucleotides in the pathogenesis of HIV-1 and simian immunodeficiency virus. J Biol Chem 2000, 275:18946-18961.
20. Loeffler J., Steffens M., Arlt E.M., Toliat M.R., Mezger M., et al. Polymorphisms in the genes encoding chemokine receptor 5, interleukin-10, and monocyte chemoattractant protein 1 contribute to cytomegalovirus reactivation and disease after allogeneic stem cell transplantation. J Clin Microbiol 2006, 44:1847-1850.
21. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007, 81:559-575.
22. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
23. Ortlepp J.R., Vesper K., Mevissen V., Schmitz F., Janssens U., et al. Chemokine receptor (CCR2) genotype is associated with myocardial infarction and heart failure in patients under 65 years of age. J Mol Med (Berl) 2003, 81:363-367.
24. Petrkova J., Cermakova Z., Drabek J., Lukl J., Petrek M. CC chemokine receptor (CCR)2 polymorphism in Czech patients with myocardial infarction. Immunol Lett 2003, 88:53-55.
25. Zhao N., Liu X., Wang Y., Li J., Yu L., et al. Association of inflammatory gene polymorphisms with ischemic stroke in a Chinese Han population. J Neuro Inflammation 2012, 9:162.
26. Kaur G., Singh P., Rapthap C.C., Kumar N., Vajpayee M., et al. Polymorphism in the CCR5 gene promoter and HIV-1 infection in North Indians. Hum Immunol 2007, 68:454-461.
27. Martin M.P., Dean M., Smith M.W., Winkler C., Gerrard B., et al. Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science 1998, 282:1907-1911.
28. Ometto L., Bertorelle R., Mainardi M., Zanchetta M., Tognazzo S., et al. Polymorphisms in the CCR5 promoter region influence disease progression in perinatally human immunodeficiency virus type 1-infected children. J Infect Dis 2001, 183:814-818.
29. Lee B., Doranz B.J., Rana S., Yi Y., Mellado M., et al. Influence of the CCR2-V64I polymorphism on human immunodeficiency virus type 1 coreceptor activity and on chemokine receptor function of CCR2b, CCR3, CCR5, and CXCR4. J Virol 1998, 72:7450-7458.
30. Sanders S.K., Crean S.M., Boxer P.A., Kellner D., LaRosa G.J., et al. Functional differences between monocyte chemotactic protein-1 receptor A and monocyte chemotactic protein-1 receptor B expressed in a Jurkat T cell. J Immunol 2000, 165:4877-4883.
31. Gawron A.J., Fought A.J., Lissowska J., Ye W., Zhang X., et al. Polymorphisms in chemokine and receptor genes and gastric cancer risk and survival in a high risk Polish population. Scand J Gastroenterol 2011, 46:333-340.
32. Breunis W.B., Biezeveld M.H., Geissler J., Kuipers I.M., Lam J., et al. Polymorphisms in chemokine receptor genes and susceptibility to Kawasaki disease. Clin Exp Immunol 2007, 150:83-90.
33. Picton A.C., Paximadis M. Tiemessen CT CCR5 promoter haplotypes differentially influence CCR5 expression on natural killer and T cell subsets in ethnically divergent HIV-1 uninfected South African populations. Immunogenetics 2012, 64:795-806.
34. Catano G., Chykarenko Z.A., Mangano A., Anaya J.M., He W., et al. Concordance of CCR5 genotypes that influence cell-mediated immunity and HIV-1 disease progression rates. J Infect Dis 2011, 203:263-272.